跳转至内容
Merck
CN

49498

Supelco

喹喔啉

analytical standard

别名:

1,4-二氮萘, 苯并 [ a ] 吡嗪, 苯并吡嗪

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C8H6N2
化学文摘社编号:
分子量:
130.15
Beilstein:
109351
EC 号:
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

analytical standard

质量水平

方案

≥98.0% (GC)

保质期

limited shelf life, expiry date on the label

技术

HPLC: suitable
gas chromatography (GC): suitable

沸点

220-223 °C (lit.)

mp

29-32 °C (lit.)

密度

1.124 g/mL at 25 °C (lit.)

应用

cleaning products
clinical
cosmetics
environmental
food and beverages
personal care

包装形式

neat

储存温度

2-8°C

SMILES字符串

c1ccc2nccnc2c1

InChI

1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H

InChI key

XSCHRSMBECNVNS-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

Quinoxaline is a synthetic non-nutritive feed additive, consisting of a quinoxaline ring moiety. The quinoxaline ring is part of a variety of antibiotics, namely actinomycin, levomycin, and echinomycin, which inhibit the growth of Gram-positive bacteria. It is also active against various transplantable tumors.

应用

Refer to the product′s Certificate of Analysis for more information on a suitable instrument technique. Contact Technical Service for further support.

包装

Bottomless glass bottle. Contents are inside inserted fused cone.

储存分类代码

11 - Combustible Solids

WGK

WGK 3


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Determination of quinoxaline antibiotics in fish feed by enzyme-linked immunosorbent assay using a monoclonal antibody
Peng J, et al.
Analytical Methods : Advancing Methods and Applications, 7(12), 5204-5209 (2015)
Catalyst?Free Protocol for the Synthesis of Quinoxalines and Pyrazines in PEG
Huang Q-T, et al.
Journal of Heterocyclic Chemistry, 50(2), 293-297 (2013)
Preparation of silver nanostructures from a new benzopyrazine silver (I) nitrate coordination polymer
Mollaee J, et al.
Inorganic Chemistry Communications, 43, 67-69 (2014)
Tony Antoniou et al.
Antiviral therapy, 19(6), 607-611 (2014-02-13)
We sought to determine the pharmacokinetic disposition of raltegravir in the blood and seminal plasma of HIV-infected men. We conducted a pharmacokinetic study using a staggered sampling approach. A total of 16 HIV-infected men receiving raltegravir-based therapy were recruited into

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持